Objective. The purpose of our study was to determine whether fetal magnetic resonance imaging (MRI) provides additional information that might affect the obstetric management of pregnancies complicated by sonographically diagnosed fetal urinary tract anomalies. Methods. Fetal MRI and sonography were used to study 39 women with suspected fetal urinary tract anomalies in the second and third trimesters of pregnancy. Results. In 24 of 39 cases (61%), fetal MRI confirmed the sonographic diagnosis. In 14 cases (36%), fetal MRI modified the initial sonographic diagnosis and counseling but did not change obstetric management. In 1 case (3%), the addition of fetal MRI resulted in a substantial change in the management of the pregnancy. Conclusions. During the second and third trimesters of pregnancy, fetal MRI showed fetal urinary tract anomalies in excellent anatomic detail. Fetal MRI is a useful complementary tool in the assessment of sonographically diagnosed fetal urinary tract anomalies. In a small percentage of cases, it can have a substantial impact on obstetric management. Key words: duplicated renal collecting system; fetal magnetic resonance imaging; fetal urinary tract anomalies; multicystic dysplastic kidneys; prenatal sonography. Abbreviations MCDK, multicystic dysplastic kidney; MRI, magnetic resonance imaging nomalies of the fetal genitourinary system occur in 0.1% to 1% of all pregnancies and account for 14% to 40% of anomalies detected by prenatal sonography.1,2 Sonography is an accurate method of evaluating the fetal genitourinary system. However, factors such as body habitus, fetal position, and oligohydramnios can prevent optimal sonographic visualization.1 Fetal magnetic resonance imaging (MRI) is increasingly used to evaluate suspected fetal anomalies, including anomalies of the genitourinary system. Fetal MRI is particularly useful in imaging fetuses with urinary tract abnormalities resulting in oligohydramnios or anhydramnios. We describe the complementary roles of sonography and MRI in the diagnosis and management of 39 cases of prenatally diagnosed fetal urinary tract abnormalities.